Pfizer CEO certain that Trump’s administration ‘will be very, very prudent with everything they try to do’. Pfizer CEO Albert Bourla has revealed that he recently dined with health secretary nominee and vaccine skeptic Robert F. Kennedy Jr. – and vaccine talk was apparently not on the menu. While the exact date of the meeting was not disclosed, Bourla said he and the health secretary nominee chatted civilly, conversing on topics they agreed on rather than straying to more divisive topics like “vaccines”.
![[The Senate Finance Committee voted to advance Robert F. Kennedy Jr.’s controversial nomination to be secretary of Health and Human Services to the full Senate Tuesday]](https://static.independent.co.uk/2025/01/29/13/35/SEI236824394.jpeg)
RFK Jr. previously spouted the false claim that “autism comes from vaccines” on numerous occasions – and has staunchly denied being anti-vax ever since, particulary since being nominated to a position in Donald Trump’s cabinet, insisting his children are vaccinated. Bourla insisted that vaccine-related discussion was not on the cards, and instead, the pair stuck to what they agreed on: “And those are things in chronic diseases, in cardiovascular diseases, and more importantly, in cancer, which is something that is very, very high in the mind of the president.
“And it is also very in the mind of Mr. Kennedy," he urged. The CEO said he remained “cautiously optimistic” about Trump’s new and revamped administration. "I think there are a lot of opportunities that probably outweigh the risks that we have with the radical change that we will see from the Trump administration," he added. In the announcement, Bourla stated: “I’m excited for what’s ahead and confident that we will enhance shareholder value as we sharpen our focus to improve the productivity of our R&D pipeline and advance the clear strategic priorities guiding our company in 2025.”.
